World Health Organization site
Skip Navigation Links

Main
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.
Register: ClinicalTrials.gov
Last refreshed on: 12 December 2020
Main ID:  NCT03423108
Date of registration: 31/01/2018
Prospective Registration: Yes
Primary sponsor: Hospital de Clinicas de Porto Alegre
Public title: Exercise Dose-response for Diabetes in the Elderly EDDIE
Scientific title: Exercise Dose-response for Diabetes in the Elderly: a Randomized Clinical Trial.
Date of first enrolment: September 10, 2018
Target sample size: 132
Recruitment status: Unknown status
URL:  https://clinicaltrials.gov/show/NCT03423108
Study type:  Interventional
Study design:  Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Treatment. Masking: Double (Investigator, Outcomes Assessor).  
Phase:  N/A
Countries of recruitment
Brazil
Contacts
Name:     Daniel Umpierre, PhD
Address: 
Telephone:
Email:
Affiliation:  Hospital de Clinicas de Porto Alegre/Federal University of Rio Grande do Sul
Name:     Angélica De Nardi, MSc
Address: 
Telephone: +55 51 3359-6332
Email: atnardi@hcpa.edu.br
Affiliation: 
Name:     Angélica De Nardi, MSc
Address: 
Telephone: +55 51 3359-6332
Email: atnardi@hcpa.edu.br
Affiliation: 
Name:     Beatriz Schaan, MD, PhD
Address: 
Telephone:
Email:
Affiliation:  Hospital de Clinicas de Porto Alegre/Federal University of Rio Grande do Sul
Key inclusion & exclusion criteria

Inclusion Criteria:

- Previous diagnosis of type 2 diabetes mellitus by HbA1c (> 6.5%) or capillary casual
glycemia (> 126 mg/dL), oral glucose tolerance test or hypoglycemic drug use;

- HbA1c = 7.5%;

- Verified ability to exercise;

- Physically inactive or regularly exercising for at least once a week.

Exclusion Criteria:

- HbA1c = 12%;

- Severe cardiovascular disease (class III or IV heart failure, uncontrolled arrhythmia,
unstable angina, or use of implantable cardioverter defibrillator);

- Major cardiovascular events 1 year previously to the enrollment (non-fatal myocardial
infarction, coronary artery bypass surgery, cardiac catheterization, deep vein
thrombosis, hospitalization or other severe health-related event);

- Chronic renal disease requesting dialysis;

- Severe macular injury (retinopathy) that disables patients to enroll an exercise
program;

- Severe cognitive impairment (dementia) that disables patients to enroll an exercise
program;

- Deafness that disables patients to enroll an exercise program;

- Blindness that disables patients to enroll an exercise program;

- Progressive neurological disorders (Parkinson, multiple sclerosis, etc.) that disables
patients to enroll an exercise program;

- Osteoarticular or muscular injuries or another health conditions which generate
inability to carry on the interventions;

- Plans of moving to another city during the study;

- Living together with another person enrolled in the study;

- A medical report indicating exercise contraindication based on a cardiopulmonary
exercise testing;

- Inability or refusal to give written consent.



Age minimum: 60 Years
Age maximum: N/A
Gender: All
Health Condition(s) or Problem(s) studied
Type2 Diabetes
Intervention(s)
Behavioral: G300
Behavioral: G150
Primary Outcome(s)
HbA1c [Time Frame: Change from baseline to 24 weeks]
Secondary Outcome(s)
Cardiorespiratory fitness [Time Frame: Change from baseline to 24 weeks]
Endothelial function [Time Frame: Change from baseline to 24 weeks]
Office Blood Pressure [Time Frame: Change from baseline to 12 weeks]
Body composition [Time Frame: Change from baseline to 24 weeks]
Lower body maximal muscle strength [Time Frame: Change from baseline to 24 weeks]
Geriatric Depression Symptoms [Time Frame: Change from baseline to 24 weeks]
HbA1c [Time Frame: Change from baseline to 12 weeks]
Intima-media thickness [Time Frame: Change from baseline to 24 weeks]
Lower limbs functional capacity [Time Frame: Change from baseline to 24 weeks]
Muscle thickness [Time Frame: Change from baseline to 24 weeks]
Muscle quality [Time Frame: Change from baseline to 24 weeks]
Quality of life (QoL) [Time Frame: Change from baseline to 24 weeks]
Endothelial function, early adaptation [Time Frame: Change from baseline to 12 weeks]
Office Blood Pressure [Time Frame: Change from baseline to 24 weeks]
Secondary ID(s)
17-0303
Source(s) of Monetary Support
Please refer to primary and secondary sponsors
Secondary Sponsor(s)
Federal University of Rio Grande do Sul
Ethics review
Results
Results available:
Date Posted:
Date Completed:
URL:
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.6 - Version history